Quantcast
Last updated on April 23, 2014 at 20:10 EDT
Space-Tested Fluid Flow Concept Advances Infectious Disease

Space-Tested Fluid Flow Concept Advances Infectious Disease Diagnoses

Melissa Gaskill, International Space Station Program Office, NASA Johnson Space Center A new medical-testing device is being prepped to enter the battle against infectious disease. This instrument could improve diagnosis of certain diseases in...

Latest Infectious diseases Stories

2014-04-23 12:30:07

Emerging Therapies Active Against Multidrug-Resistant Pathogens Will Be Preferred Over Generic Carbapenems, According to Findings from Decision Resources Group BURLINGTON, Mass., April 23, 2014 /PRNewswire/ -- Decision Resources Group finds that two emerging therapies in late-stage clinical development--AstraZeneca/Forest Laboratories' ceftazidime-avibactam and Tetraphase's eravacycline--will replace carbapenems as preferred therapies for treatment of gram-negative infections (GNIs) due to...

2014-04-22 11:46:28

A new prediction tool can help doctors better identify patients who are at highest risk for respiratory failure after surgery and therefore prevent the often deadly condition, suggest data from a large multi-center study published in the May issue of Anesthesiology. Affecting nearly 200,000 Americans a year, acute respiratory distress syndrome (ARDS) is a sudden failure of the lungs caused by a number of issues ranging from smoke inhalation to pneumonia or blood infection. High-risk...

2014-04-22 08:32:00

The largest opportunities lie in the developing regions of Asia, Africa and Latin America LONDON, April 22, 2014 /PRNewswire/ -- The diagnostics market for infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus and human papilloma virus is expanding, giving rise to commercial opportunities especially in the developing economies of Asia, Africa and Latin America. The urgent measures taken by governments to minimize healthcare expenditure,...

2014-04-18 10:09:07

New insight has the potential to improve treatment for the condition In a review published in the April issue of Immunity, Kevin J. Tracey, MD, president of The Feinstein Institute for Medical Research, says it's time to take a fresh look at the medical community's approach to treating sepsis, which kills millions worldwide every year, including more than 200,000 Americans. Sepsis occurs when molecules released into the bloodstream to fight an injury or infection trigger inflammation...

2014-04-15 12:29:40

- Oxford Early Results with CERAMENT(TM)|G show no recurrence of infection, no toxicity and no renal complications in the forty-one patients treated. LUND, Sweden, April 15, 2014 /PRNewswire/ -- BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced the first patient outcomes data of CERAMENT(TM)|G pertaining to an ongoing clinical trail in patients with...

2014-04-10 08:28:55

Accurate Norovirus Detection in as Short as One Hour SUNNYVALE, Calif., April 10, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) Norovirus, a qualitative in vitro diagnostic test for rapid identification and differentiation of Noroviruses genogroup I (GI) and genogroup II (GII), to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert(®) System, the world's...

2014-04-03 09:57:22

Little research on the treatment of rare and orphan diseases has been conducted in this area From 1997 to 2010, despite promises made by the international scientific community, pharmacogenomic research produced few studies focusing on rare, orphan and tropical diseases prevalent in developing countries. Catherine Olivier, bioethics research at the University of Montreal's School of Public Health, recently published these findings in the journal Global Public Health. Pharmcogenomics is a...

2014-04-02 12:26:12

Blood transfusions are among the most common treatments for hospitalized patients nationwide, but doing them less often reduces infection rates by nearly 20 percent, according to a study in the Journal of the American Medical Association co-authored by Neil Blumberg, M.D., professor at the University of Rochester School of Medicine and Dentistry. As director of transfusion medicine and the blood bank at UR Medicine, Blumberg for more than 25 years has been investigating how to make blood...

2014-04-01 13:13:29

Scientists have for the first time come closer to understanding how a clone of E. coli, described as the most important of its kind to cause human infections, has spread across the world in a very short time. E. coli clone ST131 is one of the leading causes of urinary tract and blood stream infections and has crossed the globe at a rapid rate. Worryingly, members of this clone are becoming more resistant to antibiotics. As an indication of scale, more than half of all women will suffer a...

Clostridium difficile
2014-03-27 05:21:42

redOrbit Staff & Wire Reports - Your Universe Online About one of 25 men and women receiving medical care in American hospitals on any given day will acquire an infection during the course of their treatment, according to new estimates released Wednesday by the US Centers for Disease Control and Prevention (CDC). According to Kim Painter of USA Today, the federal health agency report said that even though these incidents are preventable, they affect 648,000 patients per year....


Latest Infectious diseases Reference Libraries

Scandinavian Journal of Infectious Diseases
2012-05-02 19:12:54

The Scandinavian Journal of Infectious Diseases is a peer-reviewed medical journal published by Informa Healthcare, a trading division in Informa PLC, based in the United Kingdom. As of May 2012, the current editor-in-chief is Ragnar Norrby, chairman of the Board of Trustees of the International Vaccine Institute. The journal publishes original research and review articles on clinical and microbiological aspects of infectious diseases. Topics include: clinical aspects of infectious...

800px-White-footed_Mouse,_Quetico
2012-04-02 20:35:58

The White-footed Mouse, (Peromyscus leucopus), is a species of rodent native to North America. Its range extends from Ontario, Quebec, Labrador and the Maritime Provinces (excluding Newfoundland) south to the southwestern United States and Mexico. In Texas this creature is known as the Woodmouse. The adult of this species measures 3.5 to 3.9 inches in length, not counting the tail, which can measure an additional 2.5 to 3.8 inches. It weighs typically about an ounce. It has a maximum life...

0_cef863082995e6cb66fa4a692bf165a7
2011-04-28 16:37:36

Vibrio vulnificus is a species of Gram-negative, motile, curved, rod-shaped bacteria of the Vibrio Genus. Hollis et al. first reported it in 1976. It was given the name Beneckea vulnifica by Reichelt et al. in 1976 and in 1979 Vibrio vulnificus by Farmer. V. vulnificus is related to V. cholerae and is present in marine environments such as estuaries, brackish ponds, or coastal areas. It causes an infection often incurred after eating seafood, especially raw or undercooked oysters. It can...

72_219413818a409d6eca0e304d094c790a
2011-04-25 16:25:00

Mycoplasma genitalium is a small parasitic bacterium that lives on the ciliated epithelial cells of the primate genital and respiratory tracts. It is the smallest known free-living bacterium. Up until 2002 it was also considered to be the organism with the smallest genome. M. genitalium was isolated in 1980 from urethral specimens of two male patients with non-gonococcal urethritis. Infection is fairly common and can be transmitted between partners during unprotected sex. It can be treated...

72_63ad42c17b548b76aff6af345a402a04
2011-04-15 15:26:30

Haemophilus influenzae is a Gram-negative, rod-shaped bacterium first described in 1892 by Richard Pfeiffer during an influenza pandemic. It is generally aerobic but can grow as a facultative anaerobe. H. influenzae was mistakenly considered to be the cause of influenza until 1933 when the flu virology became apparent. It was the first free-living organism to have its entire genome sequenced. The project was completed and published in 1995. Two major categories were defined: the...

More Articles (15 articles) »